A phase II study of nivolumab, ipilimumab plus bicalutamide in metastatic breast cancer Meeting Abstract
| Authors: | Page, D. B.; Kaur, L.; Hong, E. C. C.; Su, A.; Moxon, N.; Mellinger, S.; Kelly, T.; Kelley, A.; Fredrich, N.; Seino, A.; Liberatore, G.; Conlin, A. K.; Topp, Z.; Perlewitz, K.; Stanton, S.; Wu, Y.; Traina, T. A.; Gucalp, A. |
| Abstract Title: | A phase II study of nivolumab, ipilimumab plus bicalutamide in metastatic breast cancer |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sept 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S379 |
| End Page: | S380 |
| Language: | English |
| ACCESSION: | WOS:001326612900381 |
| DOI: | 10.1016/j.annonc.2024.08.333 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 385P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
